Scholar Rock to Present Data from TOPAZ Outpatient Cohort Analysis at the 2022 Muscular Dystrophy Association (MDA) Clinical and Scientific Conference
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Scholarly rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on treating serious diseases in which protein growth factors play a fundamental role, today announced that it will present a poster at the 2022 Clinical & Scientific Conference of the Muscular Dystrophy Association (MDA) (March 13 – 16, 2022).Read More →